Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

In vivo anti-MUC1+ tumor activity and sequences of high-affinity anti-MUC1-SEA antibodies.

Pichinuk E, Chalik M, Benhar I, Ginat-Koton R, Ziv R, Smorodinsky NI, Haran G, Garbar C, Bensussan A, Meeker A, Guillaume T, Rubinstein DB, Wreschner DH.

Cancer Immunol Immunother. 2020 Mar 26. doi: 10.1007/s00262-020-02547-2. [Epub ahead of print]

PMID:
32219500
2.

Differential molecular regulation of processing and membrane expression of Type-I BMP receptors: implications for signaling.

Hirschhorn T, Levi-Hofman M, Danziger O, Smorodinsky NI, Ehrlich M.

Cell Mol Life Sci. 2017 Jul;74(14):2645-2662. doi: 10.1007/s00018-017-2488-y. Epub 2017 Mar 29.

PMID:
28357470
3.

FIE, a nuclear PRC2 protein, forms cytoplasmic complexes in Arabidopsis thaliana.

Oliva M, Butenko Y, Hsieh TF, Hakim O, Katz A, Smorodinsky NI, Michaeli D, Fischer RL, Ohad N.

J Exp Bot. 2016 Nov;67(21):6111-6123. Epub 2016 Oct 17.

4.

MUC1-ARF-A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA.

Chalick M, Jacobi O, Pichinuk E, Garbar C, Bensussan A, Meeker A, Ziv R, Zehavi T, Smorodinsky NI, Hilkens J, Hanisch FG, Rubinstein DB, Wreschner DH.

PLoS One. 2016 Oct 21;11(10):e0165031. doi: 10.1371/journal.pone.0165031. eCollection 2016.

5.

Active immunization against vasoactive intestinal polypeptide decreases neuronal recruitment and inhibits reproduction in zebra finches.

Vistoropsky Y, Heiblum R, Smorodinsky NI, Barnea A.

J Comp Neurol. 2016 Aug 15;524(12):2516-28. doi: 10.1002/cne.23971. Epub 2016 Feb 15.

PMID:
26801210
6.

MUC1/SEC and MUC1/Y overexpression is associated with inflammation in Sjögren's syndrome.

Sung HH, Castro I, González S, Aguilera S, Smorodinsky NI, Quest A, Bahamondes V, Alliende C, Cortés J, Molina C, Urzúa U, Barrera MJ, Hermoso M, Herrera L, Leyton C, González MJ.

Oral Dis. 2015 Sep;21(6):730-8. doi: 10.1111/odi.12339. Epub 2015 Apr 6.

PMID:
25757505
7.

Constitutive negative regulation in the processing of the anti-Müllerian hormone receptor II.

Hirschhorn T, di Clemente N, Amsalem AR, Pepinsky RB, Picard JY, Smorodinsky NI, Cate RL, Ehrlich M.

J Cell Sci. 2015 Apr 1;128(7):1352-64. doi: 10.1242/jcs.160143. Epub 2015 Feb 6.

8.

Dab2 inhibits the cholesterol-dependent activation of JNK by TGF-β.

Shapira KE, Hirschhorn T, Barzilay L, Smorodinsky NI, Henis YI, Ehrlich M.

Mol Biol Cell. 2014 May;25(10):1620-8. doi: 10.1091/mbc.E13-09-0537. Epub 2014 Mar 19.

9.

Cell surface-associated anti-MUC1-derived signal peptide antibodies: implications for cancer diagnostics and therapy.

Kovjazin R, Horn G, Smorodinsky NI, Shapira MY, Carmon L.

PLoS One. 2014 Jan 8;9(1):e85400. doi: 10.1371/journal.pone.0085400. eCollection 2014.

10.

Epizootic hemorrhagic disease virus induces and benefits from cell stress, autophagy, and apoptosis.

Shai B, Schmukler E, Yaniv R, Ziv N, Horn G, Bumbarov V, Yadin H, Smorodinsky NI, Bacharach E, Pinkas-Kramarski R, Ehrlich M.

J Virol. 2013 Dec;87(24):13397-408. doi: 10.1128/JVI.02116-13. Epub 2013 Oct 2.

11.

Characterization of novel multiantigenic vaccine candidates with pan-HLA coverage against Mycobacterium tuberculosis.

Kovjazin R, Shitrit D, Preiss R, Haim I, Triezer L, Fuks L, Nader AR, Raz M, Bardenstein R, Horn G, Smorodinsky NI, Carmon L.

Clin Vaccine Immunol. 2013 Mar;20(3):328-40. doi: 10.1128/CVI.00586-12. Epub 2013 Jan 2.

12.

Autoantibodies against the signal peptide domain of MUC1 in patients with multiple myeloma: Implications for disease diagnosis and prognosis.

Kovjazin R, Dubnik A, Horn G, Smorodinsky NI, Hardan I, Shapira MY, Carmon L.

Exp Ther Med. 2012 Jun;3(6):1092-1098. Epub 2012 Apr 3.

13.

Differential regulation of Smad3 and of the type II transforming growth factor-β receptor in mitosis: implications for signaling.

Hirschhorn T, Barizilay L, Smorodinsky NI, Ehrlich M.

PLoS One. 2012;7(8):e43459. doi: 10.1371/journal.pone.0043459. Epub 2012 Aug 22.

14.

Antibody targeting of cell-bound MUC1 SEA domain kills tumor cells.

Pichinuk E, Benhar I, Jacobi O, Chalik M, Weiss L, Ziv R, Sympson C, Karwa A, Smorodinsky NI, Rubinstein DB, Wreschner DH.

Cancer Res. 2012 Jul 1;72(13):3324-36. doi: 10.1158/0008-5472.CAN-12-0067. Epub 2012 Apr 16.

15.

Quantitative single cell monitoring of protein synthesis at subcellular resolution using fluorescently labeled tRNA.

Barhoom S, Kaur J, Cooperman BS, Smorodinsky NI, Smilansky Z, Ehrlich M, Elroy-Stein O.

Nucleic Acids Res. 2011 Oct;39(19):e129. doi: 10.1093/nar/gkr601. Epub 2011 Jul 27.

16.

ImMucin: a novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors.

Kovjazin R, Volovitz I, Kundel Y, Rosenbaum E, Medalia G, Horn G, Smorodinsky NI, Brenner B, Carmon L.

Vaccine. 2011 Jun 24;29(29-30):4676-86. doi: 10.1016/j.vaccine.2011.04.103. Epub 2011 May 12.

PMID:
21570434
17.

Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks.

Moyal L, Lerenthal Y, Gana-Weisz M, Mass G, So S, Wang SY, Eppink B, Chung YM, Shalev G, Shema E, Shkedy D, Smorodinsky NI, van Vliet N, Kuster B, Mann M, Ciechanover A, Dahm-Daphi J, Kanaar R, Hu MC, Chen DJ, Oren M, Shiloh Y.

Mol Cell. 2011 Mar 4;41(5):529-42. doi: 10.1016/j.molcel.2011.02.015.

18.

Negative regulation of the endocytic adaptor disabled-2 (Dab2) in mitosis.

Chetrit D, Barzilay L, Horn G, Bielik T, Smorodinsky NI, Ehrlich M.

J Biol Chem. 2011 Feb 18;286(7):5392-403. doi: 10.1074/jbc.M110.161851. Epub 2010 Nov 19.

19.

ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1.

Horn G, Gaziel A, Wreschner DH, Smorodinsky NI, Ehrlich M.

Exp Cell Res. 2009 May 1;315(8):1490-504. doi: 10.1016/j.yexcr.2009.02.011. Epub 2009 Feb 23.

PMID:
19245809
20.

The MUC1 oncoprotein as a functional target: immunotoxin binding to alpha/beta junction mediates cell killing.

Rubinstein DB, Karmely M, Pichinuk E, Ziv R, Benhar I, Feng N, Smorodinsky NI, Wreschner DH.

Int J Cancer. 2009 Jan 1;124(1):46-54. doi: 10.1002/ijc.23910.

Supplemental Content

Loading ...
Support Center